|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
108,030,000 |
Market
Cap: |
54.46(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.4901 - $1.37 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Selecta Biosciences is a clinical-stage biopharmaceutical company. Co.'s ImmTOR® platform encapsulates rapamycin, also known as sirolimus, a Food and Drug Administration approved immunomodulator, in biodegradable nanoparticles ImmTOR is designed to induce antigen-specific immune tolerance. By combining ImmTOR with antigens of interest, Co.'s immune tolerance platform restores self-tolerance to auto-antigens in autoimmune diseases, amplify the ability of biologics (including gene therapies) and mitigate the formation of anti-drug antibodies against biologic drugs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
1,219,316 |
1,223,316 |
1,223,316 |
1,353,316 |
Total Buy Value |
$686,416 |
$689,063 |
$689,063 |
$838,862 |
Total People Bought |
1 |
1 |
1 |
2 |
Total Buy Transactions |
10 |
13 |
13 |
14 |
Total Shares Sold |
0 |
0 |
3,637 |
15,619 |
Total Sell Value |
$0 |
$0 |
$3,855 |
$23,149 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
2 |
5 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
English Emily |
SVP, Head of ManufacturingOffi |
|
2024-04-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,273 |
|
- |
|
Springer Timothy A |
Director |
|
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
826,169 |
1,927,630 |
|
- |
|
Springer Timothy A |
Director |
|
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
24,785 |
0 |
|
- |
|
Springer Timothy A |
Director |
|
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,130,846 |
4,379,899 |
|
- |
|
Springer Timothy A |
Director |
|
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
123,925 |
0 |
|
- |
|
Singer Michael |
Director |
|
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
643,630 |
96,219 |
|
- |
|
Singer Michael |
Director |
|
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
110,151 |
119,754 |
|
- |
|
Kalayoglu Murat |
Director |
|
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
2,926,764 |
3,036,887 |
|
- |
|
Kalayoglu Murat |
Director |
|
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
491,853 |
506,377 |
|
- |
|
Seven One Eight Three Four Irrevocable Trust |
10% Owner |
|
2024-04-08 |
4 |
A |
$0.00 |
$0 |
I/I |
3,418,617 |
506,377 |
|
- |
|
Springer Timothy A |
Director |
|
2024-03-26 |
4 |
OE |
$1.46 |
$2,876,847 |
I/I |
1,970,443 |
33,043,849 |
|
- |
|
Springer Timothy A |
Director |
|
2024-03-18 |
4 |
B |
$0.61 |
$488 |
I/I |
800 |
104,818 |
2.17 |
-20% |
|
Springer Timothy A |
Director |
|
2024-03-18 |
4 |
B |
$0.60 |
$11,398 |
I/I |
19,044 |
31,073,406 |
2.17 |
-20% |
|
Springer Timothy A |
Director |
|
2024-03-15 |
4 |
B |
$0.56 |
$672 |
I/I |
1,200 |
104,018 |
2.17 |
-13% |
|
Springer Timothy A |
Director |
|
2024-03-15 |
4 |
B |
$0.59 |
$314,545 |
I/I |
537,500 |
31,054,362 |
2.25 |
-13% |
|
Springer Timothy A |
Director |
|
2024-03-14 |
4 |
B |
$0.53 |
$1,061 |
I/I |
2,000 |
102,818 |
2.17 |
-6% |
|
Springer Timothy A |
Director |
|
2024-03-14 |
4 |
B |
$0.54 |
$351,677 |
I/I |
648,372 |
30,516,862 |
2.25 |
-6% |
|
Springer Timothy A |
Director |
|
2024-03-13 |
4 |
B |
$0.58 |
$1,868 |
I/I |
3,200 |
100,818 |
2.17 |
-8% |
|
Springer Timothy A |
Director |
|
2024-03-12 |
4 |
B |
$0.61 |
$735 |
I/I |
1,200 |
97,618 |
2.17 |
-14% |
|
Springer Timothy A |
Director |
|
2024-03-11 |
4 |
B |
$0.65 |
$785 |
I/I |
1,200 |
96,418 |
2.17 |
-21% |
|
Springer Timothy A |
Director |
|
2024-03-08 |
4 |
B |
$0.66 |
$3,187 |
I/I |
4,800 |
95,218 |
2.17 |
-21% |
|
Springer Timothy A |
Director |
|
2024-02-07 |
4 |
B |
$0.66 |
$1,575 |
I/I |
2,400 |
90,418 |
2.17 |
-22% |
|
Springer Timothy A |
Director |
|
2024-02-06 |
4 |
B |
$0.65 |
$520 |
I/I |
800 |
88,018 |
2.17 |
-26% |
|
Springer Timothy A |
Director |
|
2024-01-17 |
4 |
B |
$0.69 |
$552 |
I/I |
800 |
87,218 |
2.17 |
-30% |
|
Davis Blaine |
Chief Financial Officer |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,424,000 |
2,424,000 |
|
- |
|
258 Records found
|
|
Page 1 of 11 |
|
|